Publications by authors named "Joy Poroye"
Article Synopsis
- - Dermatomyositis (DM) is a rare autoimmune disease affecting the skin and is often difficult to treat, with standard medications sometimes ineffective; lenabasum, a selective cannabinoid receptor 2 agonist, shows promise in managing these skin-related symptoms.
- - In a study involving a 3-year open-label extension of a Phase 2 trial with 20 patients resistant to traditional treatments, researchers assessed the long-term effectiveness and recurrence of DM symptoms while on lenabasum.
- - Results indicated significant improvements in skin disease activity and stability, with 58.3% of patients maintaining stable conditions and a notable reduction in flare-ups, suggesting lenabasum as a viable treatment for difficult-to-manage DM cases. *
